Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
145.18B
Market cap145.18B
Price-Earnings ratio
14.95
Price-Earnings ratio14.95
Dividend yield
6.71%
Dividend yield6.71%
Average volume
49.85M
Average volume49.85M
High today
$25.65
High today$25.65
Low today
$25.09
Low today$25.09
Open price
$25.46
Open price$25.46
Volume
51.76M
Volume51.76M
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

With a market cap of 145.18B, Pfizer(PFE) trades at $25.52. The stock has a price-to-earnings ratio of 14.95 and currently yields dividends of 6.7%.

On 2026-01-20, Pfizer(PFE) stock moved within a range of $25.09 to $25.65. With shares now at $25.52, the stock is trading +1.7% above its intraday low and -0.5% below the session's peak.

Trading volume for Pfizer(PFE) stock has reached 51.76M, versus its average volume of 49.85M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

PFE News

Benzinga 6h
Novavax Shares Rise After Licensing Deal With Pfizer

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Tuesday after the company announced it entered into a license agreement with Pfizer, Inc. (NYSE:PFE) for u...

Novavax Shares Rise After Licensing Deal With Pfizer
TipRanks 9h
GSK, Shionogi reach agreement with Pfizer for interest in ViiV Healthcare

GSK (GSK) and Shionogi & Co announced that they have reached agreement together with Pfizer (PFE) for the 11.7% economic interest in ViiV Healthcare Limited cur...

TipRanks 10h
Novavax enters license agreement with Pfizer for use of Matrix-M

Novavax (NVAX) has entered into a license agreement with Pfizer (PFE) for use of Novavax’s Matrix-M adjuvant. Under the terms of the agreement, Pfizer will obta...

Analyst ratings

57%

of 28 ratings
Buy
39.3%
Hold
57.1%
Sell
3.6%

More PFE News

The Motley Fool 1d
Down 55%, Should You Buy the Dip on Pfizer?

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard? Pfizer (PFE 0.93%) is in the Wall Street doghouse. I...

Down 55%, Should You Buy the Dip on Pfizer?
Nasdaq 1d
What to Expect From Pfizer's Non-Oncology Business in Q4?

Pfizer PFE is set to release its fourth-quarter and full-year 2025 results on Feb. 3, with investor attention focused on oncology sales, which generate more tha...

What to Expect From Pfizer's Non-Oncology Business in Q4?
Nasdaq 2d
Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026

Key Points These five stocks offer dividend yields of up to 9.4%. They represent different sectors, including communication services, energy, financials, heal...

Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026
The Motley Fool 3d
The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer and United Parcel Service

All three of these stocks sport dividend yields above 6%. If you're in the market for some no-brainer dividend stocks, I have some good and less-good news for...

The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer and United Parcel Service
TipRanks 4d
Notable open interest changes for January 16th

Thursday’s total option volume of 76.7 million contracts resulted in net open interest growth of 7.52 million calls and 5.23 million puts. Pfizer (PFE), NVIDIA...

Simply Wall St 5d
Has The Market Overlooked Pfizer After The Post‑Pandemic Reset?

If you are wondering whether Pfizer's current share price fairly reflects its fundamentals, you are not alone. This article is designed to help you weigh that u...

Has The Market Overlooked Pfizer After The Post‑Pandemic Reset?
TipRanks 5d
Pfizer Advances Prazosin Manufacturing Shift With New Bioequivalence Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .